FLT3LG anticorps (N-Term)
Aperçu rapide pour FLT3LG anticorps (N-Term) (ABIN635754)
Antigène
Voir toutes FLT3LG AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- Flt3 Ligand antibody was raised against the N terminal of FLT3 LG
-
Purification
- Affinity purified
-
Immunogène
- Flt3 Ligand antibody was raised using the N terminal of FLT3 LG corresponding to a region with amino acids TVLAPAWSPTTYLLLLLLLSSGLSGTQDCSFQHSPISSDFAVKIRELSDY
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
Flt3 Ligand Blocking Peptide, (ABIN5613619), is also available for use as a blocking control in assays to test for specificity of this Flt3 Ligand antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of FLT0 G antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- FLT3LG (Fms-Related tyrosine Kinase 3 Ligand (FLT3LG))
-
Autre désignation
- Flt3 Ligand
-
Sujet
- FLT3LG stimulates the proliferation of early hematopoietic cells and synergizes well with a number of other colony stimulating factors and interleukins.
-
Poids moléculaire
- 26 kDa (MW of target protein)
-
Pathways
- Signalisation RTK
Antigène
-